The Role of Recombinant Secretory Leukocyte Protease Inhibitor to CD163, FGF-2, IL-1 and IL-6 Expression in Skin Wound Healing

BACKGROUND: The wound healing process can be optimized through the addition of a biomaterial such as recombinant secretory leukocyte protease inhibitor (rSLPI). The SLPI is a non-glycosylated proteomic material that inhibits protease enzymes and has anti-inflammatory properties, thus accelerating wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Munadziroh, Elly, Putri, Giovani Anggasta, Ristiana, Vera, Agustantina, Titien Hary, Nirwana, Intan, Razak, Fathilah Abdul, Surboyo, Meircurius Dwi Condro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124476/
https://www.ncbi.nlm.nih.gov/pubmed/35611048
http://dx.doi.org/10.2147/CCID.S358897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124476/
https://www.ncbi.nlm.nih.gov/pubmed/35611048
http://dx.doi.org/10.2147/CCID.S358897

Ejemplares similares